Microbiologic aspects of chronic ambulatory peritoneal dialysis.
D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D005260:Female; D006801:Humans; D009504:Neutrophils / Q000382:microbiology; D009994:Osmolar Concentration; D010530:Peritoneal Dialysis / Q000009:adverse effects*; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects*; D010538:Peritonitis / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D010587:Phagocytosis; D011141:Polyuria / Q000628:therapy; D006435:Renal Dialysis; D013203:Staphylococcal Infections / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D013211:Staphylococcus aureus / Q000302:isolation & purification; D014552:Urinary Tract Infections / Q000628:therapy
D000900:Anti-Bacterial Agents